HDAC1 and cholangiocarcinoma: The major results from the present study revealed that HDAC1 was highly expressed in CC clinical samples and cells, whereas shRNA-induced silencing of HDAC1 contributed to prevention against CC progression, supported by the restrained proliferative, migratory and invasive capabilities of CC cells.